Exchange: NASDAQ·Updated 04:10 PM EST

TELA News

News
all
press releases
TELA Bio Q3 2026 Earnings Call Transcript
TELA Bio (NASDAQ:TELA) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
Benzinga
TELA Bio Q3 2026 Earnings Call Transcript
TELA Bio (NASDAQ:TELA) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
Benzinga
More News
TELA Bio (TELA) delivered earnings and revenue surprises of +31.58% and +0.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of -8.70% and -24.24%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Oculis Holding AG (OCS) delivered earnings and revenue surprises of +24.49% and -96.93%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
(RTTNews) - Medical technology company TELA Bio, Inc. (TELA) announced Monday that its Liora Monofilament Scaffold product was granted 510(k) clearance by the U.S. Food and Drug Administration...
Nasdaq News: Markets
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
TELA Bio (TELA) delivered earnings and revenue surprises of -17.65% and -3.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Puma Biotech (PBYI) delivered earnings and revenue surprises of +90.00% and +6.27%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
(RTTNews) - On Tuesday, TELA Bio, Inc. (TELA), a commercial-stage medical technology company for soft tissue reconstruction, announced the appointment of Heather Getz as Chief Executive Officer and Director, effective today...
Nasdaq News: Markets

Advertisement|Remove ads.